Research Blog

Research Update - June 2022

There are exciting things ahead with the upcoming launch of our new 5-year strategy and a growing research team Read more

In 2022 we are aiming to improve and increase patient representation in neuroblastoma research. This spotlight on research advocacy explains exactly what that means and how we will achieve it. Read more

Relapse Prevention Therapies: an in-depth look

In this special edition of our research blog, Research Director and Chair of Trustees Nick Bird looks at the landscape of maintenance therapies and their accessibility in the UK. Read more

Neuroblastoma Parent Global Symposium 2021- A round-up

Read the highlights of our second virtual parent conference hosted with Solving Kids' Cancer Us and the Children's Neuroblastoma Cancer Foundation Read more

Research Update - December 2021

Heading into Winter, we have lots of exciting updates from the Research team at Solving Kids' Cancer Read more

Behind the Research: Felix's Incredible Legacy

After losing his battle with neuroblastoma aged 6, Felix left an incredible legacy which will help countless children just like him. Read more

Research Update- September 2021

The summer months are always busy here for team SKC with lots of exciting things around the corner in Autumn to prepare for. Read more

Research Explainer: How do ALK gene alterations affect the clinical outcome for patients with high-risk neuroblastoma?

Find out more about the latest breakthrough from researchers across Europe on the significance of ALK gene alterations in high-risk neuroblastoma. Read more

An AMRC Member Charity: What does it mean?

In 2018, we announced our awarded membership to the Association of Medical Research Charities (AMRC), but what does this actually mean for our research? Read more

Research Update - June 2021

The Spring months have been as busy as ever for our research team, with the announcement of our latest project as well as progress reviews for our ongoing work and looking ahead at the SKC research strategy for the coming years. Read more

Exploring the Statistics Behind Neuroblastoma in the UK

A closer look into the National Cancer Registration and Analysis Service (NCRAS) 2021 report on cancer in children, teenagers and young adults. Read more

Research Explainer: Single Cell Study Finds Sympathoblasts as the Root of Neuroblastoma

Last month, researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital and Princess Máxima Centre published a new single cell study that has shown all neuroblastomas arise from one type of developmental cell called sympathoblasts. We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients. Read more

Latest

100 Miles for Jessica

To help raise money for critical treatment for Jessica Butler
Lucy’s Skydive for Jude

I am taking on this challenge to fundraise to help get my son, Jude, to target to access the bivalent vaccine in New York
Raffle for Jude

Jude is 4. He lives in Sheffield with his family. He is battling cancer & needs pioneering treatment in America. We can help get him there…
Rock N Roll for Kayla

Kayla from Norwich is facing a huge challenge, so rock n rollers unite.

Beau's Campaign

Beau was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in December 2020. Her family are appealing for your help to raise £317,000 by May 2022.
Flora's Campaign

In January 2021 Flora was diagnosed with Autism Spectrum Disorder, and just three months later her parents were given the devastating news she had high-risk neuroblastoma. Her family are appealing for your help to raise £252,000 by August 2022 for Flora to enrol on the Bivalent Vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.
Jude's Campaign

Jude is a Dinosaur and animal-loving three-year-old. In July 2021 Jude was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.
Joseph Yeandle

We are devastated to share the news that beautiful Joseph has sadly passed away.
Maysaa's Campaign

Four-year-old Maysaa was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in March 2021. Her family are asking for your support to raise £106,000 by August 2022 for Maysaa to enrol on the DFMO study in Charlotte that aims to stop her neuroblastoma from coming back.
Chloe’s Journey

Beautiful Chloe passed away on the 4th of February 2022.
Eden's Campaign

Six-year-old Eden was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in April 2021.
Kayla's Campaign

Three-year-old Kayla was diagnosed with high-risk neuroblastoma in May 2021. Kayla’s parents are asking for your help to raise £221,000 by November 2022 for Kayla to enrol on the bivalent vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.
Peter's Campaign

11-year-old Peter was diagnosed with neuroblastoma in early 2019. Devastatingly he relapsed in August 2020 after being clear of disease for 6 months. Thanks to your incredible fundraising and support, Peter was able to enrol on the DFMO study in Charlotte at the end of January 2022.
Dulcie's Campaign

In December 2021, five-year-old Dulcie was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.